Papers: 10.1186/bcr3191
https://doi.org/10.1186/bcr3191
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer
Cited by: 39
Author(s): Marion T. Weigel, Zara Ghazoui, Anita K. Dunbier, Sunil Pancholi, Mitch Dowsett, Lesley-Ann Martin
Published: about 14 years ago
Software Mentions 1
bioconductor: ArrayExpress
Access the ArrayExpress Collection at EMBL-EBI Biostudies and build Bioconductor data structures: ExpressionSet, AffyBatch, NChannelSetPapers that mentioned: 1,962
Very Likely Science (83)